Free Trial

Belite Bio (BLTE) Earnings Date, Estimates & Call Transcripts

Belite Bio logo
$56.40 -0.88 (-1.54%)
Closing price 04/17/2025 04:00 PM Eastern
Extended Trading
$56.28 -0.12 (-0.21%)
As of 04/17/2025 06:23 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Belite Bio Earnings Summary

Upcoming
Earnings Date
May. 12After Market ClosesEstimated
Consensus EPS
(Mar. 17)
-$0.30
Actual EPS
(Mar. 17)
-$0.32 Missed By -$0.02

Belite Bio posted Q4 2024 earnings on March 17, 2025, reporting an EPS of -$0.32, which missed analysts' consensus estimates of -$0.30 by $0.02. With a trailing EPS of -$1.18, Belite Bio's earnings are expected to grow next year, from ($1.17) to ($0.83) per share.

Q4 2024 Earnings Resources

BLTE Upcoming Earnings

Belite Bio's Q1 2025 earnings is scheduled for Monday, May 12, 2025, with a conference call scheduled on Tuesday, May 13, 2025 at 4:30 PM ET. Check back for transcripts, audio, and key financial metrics as they become available.

Get Belite Bio Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Belite Bio and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

BLTE Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Belite Bio Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20251-$0.37-$0.37-$0.37
Q2 20251-$0.36-$0.36-$0.36
Q3 20251-$0.36-$0.36-$0.36
Q4 20251-$0.36-$0.36-$0.36
FY 20254($1.45)($1.45)($1.45)

Belite Bio Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
5/12/2025
(Estimated)
--------
3/17/2025Q4 2024-$0.30-$0.32 -$0.02-$0.32--
11/12/2024Q3 2024-$0.30-$0.28+$0.02-$0.28--
8/9/2024Q2 2024-$0.28-$0.31 -$0.03-$0.31--
5/13/2024Q1 2024-$0.34-$0.27+$0.07-$0.27--
3/11/2024Q4 2023-$0.36-$0.25+$0.11-$0.25--
11/13/2023Q3 2023-$0.31-$0.40 -$0.09-$0.40--
8/8/2023Q2 2023-$0.23-$0.26 -$0.03-$0.26--
5/10/2023Q1 2023-$0.17-$0.33 -$0.16-$0.33--

Belite Bio Earnings - Frequently Asked Questions

Belite Bio has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, May 12th, 2025 based off last year's report dates. Learn more on BLTE's earnings history.

In the previous quarter, Belite Bio (NASDAQ:BLTE) missed the analysts' consensus estimate of ($0.30) by $0.02 with a reported earnings per share (EPS) of ($0.32). Learn more on analysts' earnings estimate vs. BLTE's actual earnings.

The conference call for Belite Bio's latest earnings report can be listened to online.
Listen to Conference Call

The conference call transcript for Belite Bio's latest earnings report can be read online.
Read Transcript

Belite Bio (NASDAQ:BLTE) has a recorded net income of -$31.63 million. BLTE has generated -$1.18 earnings per share over the last four quarters.

Belite Bio's earnings are expected to grow from ($1.17) per share to ($0.83) per share in the next year.

More Earnings Resources from MarketBeat



This page (NASDAQ:BLTE) was last updated on 4/21/2025 by MarketBeat.com Staff
From Our Partners